ENTO

Entero Therapeutics

18 hedge funds and large institutions have $5.38M invested in Entero Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$1.18M 695,504
JGC
2
J. Goldman & Co
New York
$1.1M 647,770 +69,372 +12%
GGHC
3
Gilder Gagnon Howe & Co
New York
$926K 544,606 +3,070 +0.6%
PCM
4
Parsons Capital Management
Rhode Island
$735K 432,133 +850 +0.2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$443K 260,306 +186,985 +255%
AAP
6
Ardsley Advisory Partners
Connecticut
$255K 150,000
OM
7
Opaleye Management
Massachusetts
$247K 145,000 +145,000 New
WPW
8
Waldron Private Wealth
Pennsylvania
$118K 69,835
TA
9
Tiedemann Advisors
New York
$102K 60,000
BlackRock
10
BlackRock
New York
$72K 42,313 +15,463 +58%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$57K 35,074 +35,074 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$48K 28,129 +28,129 New
RC
13
RegentAtlantic Capital
New Jersey
$34K 20,000
BFM
14
Boothbay Fund Management
New York
$23K 13,317 -9,463 -42%
Northern Trust
15
Northern Trust
Illinois
$21K 12,075
PFGIA
16
Patriot Financial Group Insurance Agency
Massachusetts
$7K 4,350 +1,250 +40%
UBS Group
17
UBS Group
Switzerland
$4K 2,443 +2,443 New
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$3K 1,500
Verition Fund Management
19
Verition Fund Management
Connecticut
-75,000 Closed
Morgan Stanley
20
Morgan Stanley
New York
-1,300 Closed
CFGS
21
Concourse Financial Group Securities
Alabama